Deadline: 04-Mar-2026
Innovate UK is inviting experienced providers to design and deliver end-to-end accelerator programmes for innovative UK-registered SMEs, with a strong focus on biomedical, health, and life sciences innovation. Selected providers will deliver structured, high-quality accelerator programmes supporting 10–15 SMEs per cohort, with total programme costs of up to £500,000.
Innovate UK Accelerator Programme Provider Competition Overview
Innovate UK has launched a competitive call for organisations to design and implement end-to-end accelerator programmes that support innovative UK-registered micro, small, and medium-sized enterprises. The competition seeks experienced providers capable of delivering structured, high-impact accelerator programmes aligned with the Biomedical Catalyst Accelerator Programme.
Purpose and Strategic Objectives
The objective of this competition is to strengthen the UK innovation ecosystem by supporting high-potential SMEs through tailored accelerator programmes. These programmes are intended to accelerate research and development, enhance commercial readiness, and improve access to expertise within the biomedical and wider health and life sciences sectors.
Key Focus Areas and Themes
Accelerator programmes must align with one or more of the following focus areas:
-
Biomedical Catalyst accelerator themes
-
Wider health and life sciences innovation topics
-
Biomedical and healthcare research and development across multiple sub-sectors
-
Commercialisation and scale-up support for innovative SMEs
Each accelerator programme is expected to support:
-
Between 10 and 15 SME participants
-
Total programme costs of up to £500,000
Programme Design and Delivery Requirements
Applicants must clearly define how they will design and deliver a high-quality accelerator programme. Proposals must include:
-
A detailed description of the accelerator programme and the strand being applied for
-
Programme format, intensity, and duration
-
Methods for delivering tailored, cohort-based support
-
Governance structures, quality assurance processes, and continuous improvement mechanisms
-
Clear plans for monitoring, evaluation, and reporting of outputs and outcomes to Innovate UK
Who Is Eligible to Apply?
Eligible applicants must meet all of the following criteria:
-
Be a single organisation (consortia are not permitted)
-
Have a proven track record of designing and delivering structured accelerator programmes
-
Demonstrate experience supporting innovative micro, small, and medium-sized enterprises
-
Operate at arm’s length from Innovate UK and UK Research and Innovation
-
Be capable of delivering a Biomedical Catalyst Accelerator Programme if selected
Provider Capacity and Track Record Expectations
Applicants must demonstrate:
-
Evidence of previous accelerator programme delivery, including scale, duration, and measurable outcomes
-
Capacity to deliver services over the full lifetime of the approved provider pool
-
Capability to manage end-to-end delivery, including participant recruitment, programme execution, and evaluation
-
Delivery activities carried out primarily within the UK
-
A clear commitment to supporting UK-registered innovative SMEs
Why This Competition Matters
This initiative enables Innovate UK to partner with high-quality delivery organisations to expand access to accelerator support for UK innovators. By strengthening SME capabilities in biomedical and health R&D, the programme contributes to:
-
Faster translation of research into real-world health solutions
-
Increased SME survival, growth, and investment readiness
-
A stronger and more competitive UK life sciences sector
How to Apply
To submit a successful application, providers should follow these steps:
-
Confirm organisational eligibility and ensure consortia arrangements are not included
-
Define the accelerator strand and thematic focus clearly
-
Develop a structured programme plan covering design, delivery, governance, and evaluation
-
Compile evidence of previous accelerator delivery and measurable SME outcomes
-
Submit the completed application through the Innovate UK application system by the stated deadline
Common Mistakes to Avoid
-
Submitting applications as a consortium rather than a single organisation
-
Failing to clearly define programme structure, intensity, or duration
-
Providing insufficient evidence of prior accelerator delivery and outcomes
-
Weak monitoring, evaluation, or reporting frameworks
-
Proposing delivery models not primarily based in the UK
Frequently Asked Questions
What is the purpose of this Innovate UK competition?
The competition aims to appoint experienced providers to deliver end-to-end accelerator programmes for innovative UK-registered SMEs.
Who can apply to be an accelerator provider?
Only single organisations with a proven track record in delivering structured accelerator programmes for innovative SMEs are eligible.
What sectors must the accelerator programmes focus on?
Programmes must focus on biomedical, health, and life sciences innovation, aligned with the Biomedical Catalyst Accelerator Programme.
How many SMEs will each accelerator programme support?
Each programme is expected to support between 10 and 15 SME participants.
What is the maximum programme budget?
Total programme costs can be up to £500,000 per accelerator programme.
Are consortia allowed to apply?
No. Applications must be submitted by a single organisation.
Conclusion
The Innovate UK Accelerator Programme Provider competition offers an important opportunity for experienced organisations to support the next generation of UK biomedical and health innovators. By delivering structured, high-quality accelerator programmes, selected providers will play a key role in strengthening SME innovation, accelerating R&D outcomes, and advancing the UK life sciences ecosystem.
For more information, visit GOV.UK.
